Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 4:13:1020858.
doi: 10.3389/fphar.2022.1020858. eCollection 2022.

Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism

Affiliations
Review

Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism

Zeli Xiang et al. Front Pharmacol. .

Abstract

A common consequence of chronic renal disease is secondary hyperparathyroidism (SHPT) and is closely related to the mortality and morbidity of uremia patients. Secondary hyperparathyroidism (SHPT) is caused by excessive PTH production and release, as well as parathyroid enlargement. At present, the mechanism of cell proliferation in secondary hyperparathyroidism (SHPT) is not completely clear. Decreased expression of the vitamin D receptor (VDR) and calcium-sensing receptor (CaSR), and 1,25(OH)2D3 insufficiency all lead to a decrease in cell proliferation suppression, and activation of multiple pathways is also involved in cell proliferation in renal hyperparathyroidism. The interaction between the parathormone (PTH) and parathyroid hyperplasia and 1,25(OH)2D3 has received considerable attention. 1,25(OH)2D3 is commonly applied in the therapy of renal hyperparathyroidism. It regulates the production of parathormone (PTH) and parathyroid cell proliferation through transcription and post-transcription mechanisms. This article reviews the role of 1,25(OH)2D3 in parathyroid cells in secondary hyperparathyroidism and its current understanding and potential molecular mechanism.

Keywords: calcitriol; chronic kidney disease; parathyroid cells; regulatory mechanisms; secondary hyperparathyroidism.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Mechanism of calcitriol in parathyroid cells. In the cell, 1,25D binds to VDR, which is translocated to the nucleus.1, 25D-bound VDR can form different complexes in different promoter regions. By binding to RXR and VDIR, it recruits histone deacetylases HDAC2 and DNA methyltransferases DNMT1 and DNMT3b to inhibit transcription of the PTH gene, thereby reducing the synthesis and secretion of PTH. 1, 25D-bound VDR induces transcription of calcium-sensing receptor (CaSR), Klotho, VDR, Let-7, c-myc, CDKN1a and CDKN1b genes by directly binding RXR to vitamin D response elements on DNA. Increased CaSR expression leads to higher sensitivity of parathyroid cells to calcium, while increased Klotho transcription results in increased sensitivity to FGF23. c-myc, p21 and p27 supress cell proliferation by inhibiting cell cycle progression. The increased transcription of Let-7 family decreased the stability of PTH mRNA. 1,25D also represses the proliferation of Parathyroid cells by reducing epidermal growth factor receptor (EGFR), Nuclear factor-KB (NF-kB), mTOR complex 1(mTORc1) and prostaglandin E2(PGE2) signaling pathways.

References

    1. Arcidiacono M. V., Cozzolino M., Spiegel N., Tokumoto M., Yang J., Lu Y., et al. (2008a). Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism. J. Am. Soc. Nephrol. 19 (10), 1919–1928. 10.1681/asn.2007111216 - DOI - PMC - PubMed
    1. Arcidiacono M. V., Sato T., Alvarez-Hernandez D., Yang J., Tokumoto M., Gonzalez-Suarez I., et al. (2008b). EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. J. Am. Soc. Nephrol. 19 (2), 310–320. 10.1681/asn.2007040406 - DOI - PMC - PubMed
    1. Bettoun D. J., Buck D. W., 2nd, Lu J., Khalifa B., Chin W. W., Nagpal S. (2002). A vitamin D receptor-Ser/Thr phosphatase-p70 S6 kinase complex and modulation of its enzymatic activities by the ligand. J. Biol. Chem. 277 (28), 24847–24850. 10.1074/jbc.C200187200 - DOI - PubMed
    1. Bikle D. D., Malmstroem S., Schwartz J. (2017). Current controversies: Are free vitamin metabolite levels a more accurate assessment of vitamin D status than total levels? Endocrinol. Metab. Clin. North Am. 46 (4), 901–918. 10.1016/j.ecl.2017.07.013 - DOI - PMC - PubMed
    1. Brown A. J., Zhong M., Finch J., Ritter C., Slatopolsky E. (1995). The roles of calcium and 1, 25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 136 (4), 1419–1425. 10.1210/endo.136.4.7895652 - DOI - PubMed

LinkOut - more resources